ROCHE HOLDING AG-BR (RHO.DE) Stock Price & Overview
FRA:RHO • CH0012032113
Current stock price
The current stock price of RHO.DE is 353.4 EUR. Today RHO.DE is up by 0.51%. In the past month the price decreased by -13.42%.
RHO.DE Key Statistics
- Market Cap
- 285.989B
- P/E
- 16.54
- Fwd P/E
- 15.75
- EPS (TTM)
- 21.37
- Dividend Yield
- 3.13%
RHO.DE Stock Performance
RHO.DE Stock Chart
RHO.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to RHO.DE.
RHO.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to RHO.DE. RHO.DE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
RHO.DE Earnings
On January 29, 2026 RHO.DE reported an EPS of 8.53 and a revenue of 30.57B. The company missed EPS expectations (-3.53% surprise) and missed revenue expectations (-3.25% surprise).
RHO.DE Forecast & Estimates
29 analysts have analysed RHO.DE and the average price target is 400.71 EUR. This implies a price increase of 13.39% is expected in the next year compared to the current price of 353.4.
For the next year, analysts expect an EPS growth of 5.01% and a revenue growth 1.49% for RHO.DE
RHO.DE Groups
Sector & Classification
RHO.DE Financial Highlights
Over the last trailing twelve months RHO.DE reported a non-GAAP Earnings per Share(EPS) of 21.37. The EPS increased by 4.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.94% | ||
| ROA | 12.79% | ||
| ROE | 38.1% | ||
| Debt/Equity | 0.85 |
RHO.DE Ownership
RHO.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SNW | SANOFI | 9.66 | 197.843B | ||
| SAN | SANOFI | 9.76 | 197.795B | ||
| 1SAN | SANOFI | 9.63 | 197.264B | ||
| UCB | UCB SA | 25.13 | 49.289B | ||
| UNC | UCB SA | 24.63 | 49.269B | ||
| MRK | MERCK KGAA | 13.01 | 46.695B | ||
| BAYN | BAYER AG-REG | 8.41 | 38.378B | ||
| 1BAYN | BAYER AG-REG | 8.23 | 37.843B | ||
| IPN | IPSEN | 13.15 | 13.074B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 17.11 | 10.227B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.191B | ||
| VIRP | VIRBAC SA | 16.42 | 2.957B | ||
| DMP | DERMAPHARM HOLDING SE | 16.83 | 2.364B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About RHO.DE
Company Profile
Roche Holding AG is a CH-based company operating in Pharmaceuticals industry. The company is headquartered in Basel, Basel-Stadt and currently employs 112,774 full-time employees. The company went IPO on 2001-05-04. Roche Holding AG (Roche) is a research-based healthcare company. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Company Info
IPO: 2001-05-04
ROCHE HOLDING AG-BR
Grenzacherstr. 124
Basel BASEL-STADT CH
Employees: 112774
Phone: 41616881111
ROCHE HOLDING AG-BR / RHO.DE FAQ
Can you describe the business of ROCHE HOLDING AG-BR?
Roche Holding AG is a CH-based company operating in Pharmaceuticals industry. The company is headquartered in Basel, Basel-Stadt and currently employs 112,774 full-time employees. The company went IPO on 2001-05-04. Roche Holding AG (Roche) is a research-based healthcare company. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
What is the stock price of ROCHE HOLDING AG-BR today?
The current stock price of RHO.DE is 353.4 EUR. The price increased by 0.51% in the last trading session.
Does ROCHE HOLDING AG-BR pay dividends?
ROCHE HOLDING AG-BR (RHO.DE) has a dividend yield of 3.13%. The yearly dividend amount is currently 0.
What is the ChartMill rating of ROCHE HOLDING AG-BR stock?
RHO.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the GICS sector and industry of RHO stock?
ROCHE HOLDING AG-BR (RHO.DE) operates in the Health Care sector and the Pharmaceuticals industry.
How many employees does ROCHE HOLDING AG-BR have?
ROCHE HOLDING AG-BR (RHO.DE) currently has 112774 employees.
What is the next earnings date for RHO stock?
ROCHE HOLDING AG-BR (RHO.DE) will report earnings on 2026-04-23.